NEON THERAPEUTICS, INC. Operating Income
NEON THERAPEUTICS, INC. reported Operating Income of -$16.67 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2020-05-01
- NEON THERAPEUTICS, INC. operating income (loss) for the quarter ending 2020-03-31 was -$16.67M.
- NEON THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-12-31 was -$17.99M.
- NEON THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-09-30 was -$19.25M.
- NEON THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-06-30 was -$22.32M.
- NEON THERAPEUTICS, INC. operating income (loss) for fiscal 2019 was -$81.14M.
- NEON THERAPEUTICS, INC. operating income (loss) for fiscal 2018 was -$78.70M.
- NEON THERAPEUTICS, INC. operating income (loss) for fiscal 2017 was -$48.09M.
- NEON THERAPEUTICS, INC. operating income (loss) for fiscal 2016 was -$27.42M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$16.67M 10-Q · filed 2020-05-01 | -$34.66M derived: sum of 2 quarters · filed 2020-05-01 | -$53.91M derived: sum of 3 quarters · filed 2020-05-01 | -$76.22M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | -$17.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$37.24M derived: sum of 2 quarters · filed 2020-03-02 | -$59.56M derived: sum of 3 quarters · filed 2020-03-02 | -$81.14M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$19.25M 10-Q · filed 2019-11-12 | -$41.57M derived: sum of 2 quarters · filed 2019-11-12 | -$63.15M 10-Q · filed 2019-11-12 | -$86.92M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | -$22.32M 10-Q · filed 2019-08-06 | -$43.90M 10-Q · filed 2019-08-06 | -$67.67M derived: sum of 3 quarters · filed 2020-05-01 | -$86.72M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | -$21.58M 10-Q · filed 2020-05-01 | -$45.35M derived: sum of 2 quarters · filed 2020-05-01 | -$64.41M derived: sum of 3 quarters · filed 2020-05-01 | -$83.52M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | -$23.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$42.83M derived: sum of 2 quarters · filed 2020-03-02 | -$61.94M derived: sum of 3 quarters · filed 2020-03-02 | -$78.70M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$19.05M 10-Q · filed 2019-11-12 | -$38.17M derived: sum of 2 quarters · filed 2019-11-12 | -$54.93M 10-Q · filed 2019-11-12 | -$69.56M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$19.12M 10-Q · filed 2019-08-06 | -$35.87M 10-Q · filed 2019-08-06 | -$50.51M derived: sum of 3 quarters · filed 2019-08-06 | -$64.65M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | -$16.76M 10-Q · filed 2019-05-13 | -$31.39M derived: sum of 2 quarters · filed 2019-05-13 | -$45.53M derived: sum of 3 quarters · filed 2019-05-13 | -$55.30M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | -$14.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$28.77M derived: sum of 2 quarters · filed 2019-03-11 | -$38.54M derived: sum of 3 quarters · filed 2019-03-11 | -$48.09M 10-K · filed 2019-03-11 |
| 2017-09-30 | -$14.14M 10-Q · filed 2018-11-13 | -$23.91M derived: sum of 2 quarters · filed 2018-11-13 | -$33.45M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | -$9.76M 10-Q · filed 2018-08-06 | -$19.31M 10-Q · filed 2018-08-06 | ||
| 2016-12-31 | -$27.42M 10-K · filed 2019-03-11 |